Botulinum Toxin Treatment of Myofascial Pain: A Critical Review of the Literature
Author:
- 10 July 2012
- journal article
- review article
- Published by Springer Nature in Current Pain and Headache Reports
- Vol. 16 (5) , 413-422
Abstract
This is a review of literature relevant to the treatment of myofascial pain syndrome by botulinum injections. The objective is to critically review the studies to see if they are appropriately designed, conducted, and interpreted to provide guidance in the management of myofascial pain. The intent is to better understand the mixed results that these studies have provided. A search was made utilizing PubMed for literature relevant to the use of botulinum toxin in the treatment of myofascial pain. All identifiable series were reviewed, including open label, single-blinded and double-blinded studies, randomized and controlled, or not. In general, small case series of only a few patients were not included unless they made a relevant point and there were no available randomized studies or larger studies. Single case reports were not included. This is not a meta-analysis. The studies were evaluated according to their design and the selection of outcome measurements, and the interpretation of results. The studies were individually critiqued, and an overall assessment and commentary was made of the studies in the field as a whole. Problems that were common to the studies were robust placebo responders, incomplete treatment of a regional myofascial pain syndrome, inappropriate or confounding control populations or treatments, and inappropriate time periods for assessment of outcomes, or misinterpretation of the time-frame of action of botulinum toxin. The studies of the effect of botulinum toxin treatment of myofascial trigger points have had mixed results. However, few studies have been designed to avoid many of the pitfalls associated with a trial of botulinum toxin treatment of trigger points. Better-designed studies may give results that can be used to guide practice based on reliable evidence. At the present time, one must conclude that the available evidence is insufficient to guide clinical practice.Keywords
This publication has 42 references indexed in Scilit:
- Botulinum toxin for myofascial pain syndromes in adults2012
- Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: A randomized, controlled, double-blind multicenter studyPain, 2011
- Botulinum toxin for subacute/chronic neck pain2011
- RimabotulinumtoxinB Effects on Pain Associated with Cervical Dystonia: Results of Placebo and Comparator-Controlled StudiesInternational Journal of Neuroscience, 2010
- Botulinum Toxin A in the Treatment of Chronic Tension‐Type Headache With Cervical Myofascial Trigger Points: A Randomized, Double‐Blind, Placebo‐Controlled Pilot StudyHeadache: The Journal of Head and Face Pain, 2009
- Effect of Botulinum Toxin-A in Myofascial Pain Patients With or Without Functional Disc DisplacementJournal of Oral and Maxillofacial Surgery, 2008
- The Analgesic Effect of Botulinum-toxin A on Postwhiplash Neck PainThe Clinical Journal of Pain, 2008
- Treatment of Refractory, Chronic Low Back Pain with Botulinum Neurotoxin A: An Open-Label, Pilot StudyPain Medicine, 2006
- Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: A randomised double blind crossover studyPain, 2005
- Temporal relationship of muscle weakness and pain reduction in subjects treated with botulinum toxin AThe Journal of Pain, 2003